Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment 2020-01-06 09:00
WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392 2020-01-02 08:08
Focusing on Cutting-edge Biopharmaceutical Technologies, Boosting the Industry to Achieve Innovation and Development 2019-12-25 12:55
EpiVax Announces Record Year for Growth in 2019 and Sets New Milestones for 2020 2019-12-24 16:35
WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters 2019-12-23 16:26
China's Largest Plasmid and Virus Facility from GenScript in Operation 2019-12-20 21:59
Getinge to Acquire Applikon Biotechnology B.V., A Leading Company in the Fast Growing Area of Bioreactor Systems 2019-12-19 18:27
Asieris Wins Questex's Fierce Innovation Awards - Life Sciences Edition 2019 2019-12-19 13:51
MoA Technology implements CDD Vault to manage its crop protection research data 2019-12-17 17:00
Novoheart Licenses Harvard Technology to Develop Next-Generation Human Heart-in-a-Jar 2019-12-16 16:05
HOYA Group PENTAX Medical Cleared CE Mark for DISCOVERY(TM), an AI Assisted Polyp Detector 2019-12-16 16:00
Drug Manufacturers Eye Analytical Instrumentation to Reduce Operating Costs 2019-12-12 23:11
CStone completes registration filing for the Phase I trial of its tumor immune microenvironment modulator CS3005 to enable study initiation in Australia 2019-12-12 14:47
Biocon Biologics Symposium on '100 Years of Insulin - Delivering on Universal Access & Equitable Care' Resonates Well With Leading KOLs at IDF Congress 2019 2019-12-12 09:00
Human Microbiome Market to Reach $6.08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics 2019-12-11 23:55
AGC Biologics Expands Plasmid DNA Offering 2019-12-11 09:06
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma 2019-12-11 08:41
Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for "Best of ASH" 2019-12-11 08:00
Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours 2019-12-09 21:01
PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided 2019-12-06 20:00
1 178 179 180 181 182 233